Filing Details
- Accession Number:
- 0001179110-13-003555
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-26 17:10:14
- Reporting Period:
- 2013-02-22
- Filing Date:
- 2013-02-26
- Accepted Time:
- 2013-02-26 17:10:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1021038 | A Henri Termeer | C/O Abiomed, Inc. 22 Cherry Hill Drive Danvers MA 01923 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 Par Value | Acquisiton | 2013-02-22 | 43,983 | $14.70 | 116,381 | No | 4 | P | Direct | |
| Common Stock, $0.01 Par Value | Acquisiton | 2013-02-25 | 56,017 | $15.20 | 172,398 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | $18.40 | 2002-08-08 | 2012-08-08 | 5,000 | 5,000 | Direct |
| Common Stock | Stock Option (right to buy) | $4.71 | 2003-08-06 | 2013-08-06 | 5,000 | 5,000 | Direct |
| Common Stock | Stock Option (right to buy) | $5.15 | 2004-08-13 | 2014-08-13 | 5,000 | 5,000 | Direct |
| Common Stock | Stock Option (right to buy) | $10.41 | 2005-08-11 | 2014-08-11 | 8,000 | 8,000 | Direct |
| Common Stock | Stock Option (right to buy) | $10.06 | 2006-08-09 | 2015-08-10 | 8,000 | 8,000 | Direct |
| Common Stock | Stock Option (right to buy) | $13.21 | 2007-08-08 | 2016-08-09 | 8,000 | 8,000 | Direct |
| Common Stock | Stock option (right to buy) | $12.69 | 2008-08-13 | 2017-08-08 | 8,000 | 8,000 | Direct |
| Common Stock | Stock Option (right to buy) | $18.63 | 2009-08-12 | 2018-08-13 | 8,000 | 8,000 | Direct |
| Common Stock | Stock Option (right to buy) | $7.67 | 2010-08-11 | 2019-08-12 | 12,000 | 12,000 | Direct |
| Common Stock | Stock Options (right to buy) | $9.99 | 2011-08-10 | 2020-08-11 | 12,000 | 12,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2012-08-08 | 5,000 | 5,000 | Direct |
| 2013-08-06 | 5,000 | 5,000 | Direct |
| 2014-08-13 | 5,000 | 5,000 | Direct |
| 2014-08-11 | 8,000 | 8,000 | Direct |
| 2015-08-10 | 8,000 | 8,000 | Direct |
| 2016-08-09 | 8,000 | 8,000 | Direct |
| 2017-08-08 | 8,000 | 8,000 | Direct |
| 2018-08-13 | 8,000 | 8,000 | Direct |
| 2019-08-12 | 12,000 | 12,000 | Direct |
| 2020-08-11 | 12,000 | 12,000 | Direct |
Footnotes
- Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 1989 Non-Qualified Stock Option Plan for Non-Employee Directors.
- This option becomes exercisable in full on the date set forth in Table II, Column 6.
- Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2000 Stock Incentive Plan.
- Grant to reporting person of option to buy shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- This price represents the weighted average purchase price of multiple transactions on the reported date at prices that ranged between $14.6200 and $14.7000. Detailed information regarding the number of shares purchased at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the issuer.
- This price represents the weighted average purchase price of multiple transactions on the reported date at prices that ranged between $14.7000 and $15.2500. Detailed information regarding the number of shares purchased at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the issuer.
Billionaire Hedge Funds
